Study for anticoagulantion strategy guided by risk stratification in patients with ventricular aneurysm after myocardial infarction

Study for anticoagulantion strategy in patients with ventricular aneurysm

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031548

Enrollment

Unknown

Registered

2020-04-04

Start date

2020-07-01

Completion date

Unknown

Last updated

2020-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

left ventricular aneurysm after myocardial infarction

Interventions

high risk of mural thrombus:prophylatic anticoagulantion

Control group:Conventional treatment

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged <=80 years; 2. definite history of myocardial infarction; 3. ventricular aneurysm diagnosed by echocardiography or CMR.

Exclusion criteria

Exclusion criteria: 1. significant indication of anticoagulant therapy in patients including atrial fibrillation, cardiac valve replacement, pulmonary embolism, venous thrombosis and etc.; 2. History of massive bleeding in the past 12 months, other contraindications of anticoagulant; 3. Elective surgery is planned for nearly 6 months; 4. Malignant tumor, severe liver and kidney failure, severe anemia or expected survival less than 6 months; 5. Disagreement of participation.

Design outcomes

Primary

Measure	Time frame
Cardiac ultrasound;	—

Secondary

Measure	Time frame
Cardiac magnetic resonance;	—

Countries

China

Contacts

Public ContactCuilian Dai

Xiamen Cardiovascular Hospital, Xiamen University

guomingheart@126.com+86 18060903796

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026